# Cochrane

# Trusted evidence.

# Informed decisions.

# Better health.

# Cochrane Database of Systematic Reviews

# Outcome or subgroup title

|Outcome or subgroup title|No. of studies|No. of participants|Statistical method|Effect size|
|---|---|---|---|---|
|2.3 Maintenance of clinical remission in UC: sensitivity analysis for available cases|2|64|Risk Ratio (M-H, Random, 95% CI)|1.66 [0.47, 5.81]|
|2.4 Serious adverse events for maintenance of remission in UC|2|0|Risk Ratio (M-H, Random, 95% CI)|Not estimable|
|2.5 Any adverse events for maintenance of remission in UC|2|71|Risk Ratio (M-H, Random, 95% CI)|1.16 [0.85, 1.59]|
|2.6 Maintenance of endoscopic remission in UC|2|71|Risk Ratio (M-H, Random, 95% CI)|3.28 [0.73, 14.74]|
|2.7 Withdrawals in studies on maintenance of remission in UC|2|71|Risk Ratio (M-H, Random, 95% CI)|0.30 [0.05, 1.73]|
|2.8 Erythrocyte sedimentation rate (ESR) at longest follow-up for maintenance of remission in UC (mm/hour)|1|61|Mean Difference (IV, Random, 95% CI)|-10.40 [-12.54, -8.26]|
|2.9 C-reactive protein (CRP) at longest follow-up for maintenance of remission in UC (mg/L)|1|61|Mean Difference (IV, Random, 95% CI)|-2.70 [-3.82, -1.58]|

# Analysis 2.1. Comparison 2: Fecal microbiota transplantation (FMT) versus control for maintenance of remission in ulcerative colitis (UC), Outcome 1: Maintenance of clinical remission in UC

|Study or Subgroup|FMT Events|FMT Total|Control Events|Control Total|Weight|Risk Ratio M-H, Random, 95% CI|Risk Ratio M-H, Random, 95% CI|Risk of Bias|
|---|---|---|---|---|---|---|---|---|
|Haifer 2022|4|4|0|6|36.3%|12.60 [0.86, 185.05]| |+ + + + + + +|
|Sood 2019a (1)|27|31|20|30|63.7%|1.31 [0.98, 1.74]| |+ ? + + + +|
|Total (95% CI)| |35| |36|100.0%|2.97 [0.26, 34.42]| | |

Total events: 31 / 20

Heterogeneity: Tau² = 2.43; Chi² = 3.56, df = 1 (P = 0.06); I² = 72%

Test for overall effect: Z = 0.87 (P = 0.38)

Favors FMT Favors control

Test for subgroup differences: Not applicable

# Footnotes

(1) Mayo score ≤ 2 with all subscores ≤ 1 at week 48.

# Risk of bias legend

(A) Random sequence generation (selection bias)

(B) Allocation concealment (selection bias)

(C) Blinding of participants and personnel (performance bias)

(D) Blinding of outcome assessment (detection bias)

(E) Incomplete outcome data (attrition bias)

(F) Selective reporting (reporting bias)

(G) Other bias

# Fecal transplantation for treatment of inflammatory bowel disease (Review)

Copyright © 2023 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.